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The proviral load (PVL) in HTLV-1 infection is strongly
correlated with odds of the inflammatory disease HAM/
TSP. Individuals with HLA class I alleles which can bind
HBZ have reduced PVL and reduced risk of HAM/TSP.
We tested the hypothesis that a strong CD8+ T-cell
response to HBZ alters the frequency distribution of
infected T-cell clones and selects the genomic environ-
ment of the proviral integration site (IS) in vivo. We used
our recently described high-throughput protocol to map
and quantify IS in 95 HAM/TSP patients and 68 asympto-
matic carriers (ACs) from Kagoshima, Japan, and 75 ACs
from Kumamoto, Japan. Individuals with 2 or more HLA
class I alleles predicted to bind HBZ were classified as
‘strong’ HBZ binders. The results suggest that the pre-
dicted strength of HBZ binding does not influence the
overall clone frequency distribution. However, clonal
abundance was correlated with frequency of proviral inte-
gration within transcriptionally active areas in weak HBZ
binders, but not strong HBZ binders. IS in transcription-
ally active areas were more frequent in ACs than HAM/
TSP, irrespective of clone abundance or HBZ binding
strength, and were more frequent in strong HBZ binders
than weak binders in low-abundance clones only. We pro-
pose that proviral integration in transcriptionally active
areas of the genome conveys a proliferation advantage on
the infected T-cell clone, but the equilibrium abundance
of that clone is limited by stronger immune selection in
ACs. A strong CD8+ T-cell response to HBZ may remove
this advantage, perhaps by selecting against high HBZ
expression.
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